Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Russell Barton

COO at Acumen Pharmaceuticals, Inc. (ABOS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $30K

Reported trades

Filed Stock Type Shares Price Value Since
Jan 23SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 2,315205,554 held (−1%) $1.81 $4K +18.2%
Jan 23SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 462205,092 held (−0%) $1.84 $850 +16.3%
Jan 12SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 3,530123,269 held (−3%) $1.86 $7K +15.1%
Jan 7SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 4,000132,117 held (−3%) $1.96 $8K +9.2%
Jan 7SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 3,618128,499 held (−3%) $1.97 $7K +8.6%
Jan 7SEC ABOSAcumen Pharmaceuticals, Inc. Sell Plan 1,700126,799 held (−1%) $1.99 $3K +7.5%
  • Sell

    COO Russell Barton sold $4K of ABOS at $1.81 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Russell Barton sold $850 of ABOS at $1.84 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Russell Barton sold $7K of ABOS at $1.86 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Russell Barton sold $8K of ABOS at $1.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Russell Barton sold $7K of ABOS at $1.97 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Russell Barton sold $3K of ABOS at $1.99 — pre-scheduled 10b5-1 plan sale.